Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TOR Serine-Threonine Kinases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00457964
What this trial is testing

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosis
Children's Hospital Medical Center, Cincinnati 36
Early research (Phase 1)Study completedNCT01353625
What this trial is testing

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.

Who this might be right for
Glioblastoma MultiformeSquamous Cell Carcinoma of Head and NeckProstate Cancer+3 more
Celgene 118
Not applicableEnded earlyNCT03946774
What this trial is testing

Dietary Protein and Monocyte/Macrophage Mammalian Target of Rapamycin (mTOR) Signaling

Who this might be right for
Dietary Protein
Washington University School of Medicine 21
Testing effectiveness (Phase 2)Study completedNCT02874924
What this trial is testing

Effect of mTOR Inhibition and Other Metabolism Modulating Interventions on the Elderly

Who this might be right for
Aging
The University of Texas Health Science Center at San Antonio 34
Early research (Phase 1)Study completedNCT03730142
What this trial is testing

WXFL10030390 in Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Advanced Cancer
Shanghai Jiatan Pharmatech Co., Ltd 82
Early research (Phase 1)Study completedNCT00973076
What this trial is testing

Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055

Who this might be right for
CancerSolid TumorsAdvanced Solid Malignancies
AstraZeneca 19
Post-approval studies (Phase 4)Study completedNCT01046045
What this trial is testing

Everolimus Rescue Immunosuppression in the Treatment of Chronic Allograft Dysfunction in Renal Transplant Recipients

Who this might be right for
Chronic Allograft Dysfunction in Renal Transplantation
Chinese University of Hong Kong 17
Early research (Phase 1)WithdrawnNCT01194193
What this trial is testing

Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours

Who this might be right for
CancerAdvanced Solid TumoursLymphomas
AstraZeneca 63
Testing effectiveness (Phase 2)Study completedNCT00093080
What this trial is testing

Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)

Who this might be right for
LeiomyosarcomaLiposarcomaOsteosarcoma+2 more
Merck Sharp & Dohme LLC 216
Post-approval studies (Phase 4)UnknownNCT03767660
What this trial is testing

Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation

Who this might be right for
Blue Rubber Bleb Nevus SyndromeVenous Malformation
Peking Union Medical College Hospital 20
Early research (Phase 1)Study completedNCT02238496
What this trial is testing

Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas

Who this might be right for
Brain Tumor, RecurrentGlioblastomaAnaplastic Astrocytoma+2 more
Andrew B Lassman, MD 10
Testing effectiveness (Phase 2)Study completedNCT00353301
What this trial is testing

Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
University of Colorado, Denver 25
Not applicableStudy completedNCT01632605
What this trial is testing

The Vienna RAP Pilot Study

Who this might be right for
ADPKD
Medical University of Vienna 8
Large-scale testing (Phase 3)UnknownNCT03987152
What this trial is testing

Treatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of Life

Who this might be right for
Vascular Malformations
Radboud University Medical Center 75
Testing effectiveness (Phase 2)Study completedNCT01070316
What this trial is testing

Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)

Who this might be right for
EpilepsyTuberous Sclerosis Complex
Children's Hospital Medical Center, Cincinnati 20
Early research (Phase 1)Study completedNCT00999882
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer Patients

Who this might be right for
CancerAdvanced Hepatocellular Carcinoma
AstraZeneca 26
Testing effectiveness (Phase 2)Study completedNCT00331409
What this trial is testing

Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
OHSU Knight Cancer Institute 23